Period Ending | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 |
Total Revenue
|
32,396,000
|
51,324,000
|
44,958,000
| Cost of Revenue | 24,931,000 | 38,415,000 | 32,626,000 | |
Gross Profit
|
7,465,000
|
12,909,000
|
12,332,000
| |
|
Operating Expenses |
|
Research Development | 1,421,000 | 1,728,000 | 1,404,000 |
|
Selling General and Administrative | 5,467,000 | 4,399,000 | 4,875,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
577,000
|
6,782,000
|
6,053,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 381,000 | (882,000) | 320,000 |
|
Earnings Before Interest And Taxes | 958,000 | 5,900,000 | 6,373,000 |
|
Interest Expense | 389,000 | 1,427,000 | 1,420,000 |
|
Income Before Tax | 569,000 | 4,473,000 | 4,953,000 |
|
Income Tax Expense | (270,000) | 953,000 | 1,485,000 |
|
Minority Interest | 68,000 |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 895,000 | 3,557,000 | 3,541,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
895,000
|
3,557,000
|
3,541,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
$895,000
|
$3,557,000
|
$3,541,000
|
|